theory clinical_31_3
imports Main

begin

typedecl entity
typedecl event

consts
  BetaCatenin :: "entity ⇒ bool"
  Expression :: "entity ⇒ bool"
  Gene :: "entity ⇒ bool"
  CyclinD1 :: "entity ⇒ bool"
  Activate :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  NecessaryFor :: "entity ⇒ entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Activity :: "entity ⇒ bool"
  Enhance :: "event ⇒ bool"
  Lead :: "event ⇒ bool"
  Promote :: "event ⇒ bool"
  DueTo :: "event ⇒ event ⇒ bool"
  Directly :: "event ⇒ bool"
  Cell :: "entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"

(* Explanation 1: β-catenin activates the expression of many genes, including cyclin D1, which is necessary for cell proliferation. *)
axiomatization where
  explanation_1: "∃x y z e. BetaCatenin x ∧ Expression y ∧ Gene z ∧ CyclinD1 z ∧ Activate e ∧ Agent e x ∧ Patient e y ∧ NecessaryFor y z ∧ Proliferation z"

(* Explanation 2: Activating mutations of CTNNB1 enhance the activity of β-catenin, leading to increased expression of genes like cyclin D. The increased expression of cyclin D1, due to enhanced β-catenin activity, directly promotes cell proliferation. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2 e3. Mutation x ∧ CTNNB1 y ∧ BetaCatenin z ∧ Activity z ∧ Gene w ∧ CyclinD1 w ∧ Expression w ∧ Enhance e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Lead e2 ∧ Agent e2 z ∧ Patient e2 w ∧ Promote e3 ∧ Agent e3 w ∧ Patient e3 z ∧ DueTo e3 e1 ∧ Directly e3 ∧ Proliferation z"

theorem hypothesis:
  assumes asm: "Mutation x ∧ CTNNB1 y ∧ Cell z"
  (* Hypothesis: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
  shows "∃x y z e. Mutation x ∧ CTNNB1 y ∧ Cell z ∧ Proliferation z ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y"
proof -
  (* From the premise, we have known information about Mutation x, CTNNB1 y, and Cell z. *)
  from asm have "Mutation x ∧ CTNNB1 y ∧ Cell z" by meson
  (* Explanation 2 provides a logical relation: Implies(D, C), which means activating mutations of CTNNB1 enhance the activity of β-catenin, leading to cell proliferation. *)
  (* Since we have Mutation x and CTNNB1 y, we can infer that β-catenin activity is enhanced, leading to cell proliferation. *)
  from explanation_2 have "∃e. Proliferation z ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y" sledgehammer
  then show ?thesis <ATP>
qed

end
